StrategyCorp adds Carol Devenny and Michelle Gagnon as senior advisors
Source: Consultancy
She has also been an adjunct professor at the Cumming School of Medicine at the University of Calgary for the last seven years, and in 2017 co-founded Pemi31 Therapeutics, a biotech startup that focuses on immune therapy for inflammatory diseases.
Subscribe Now

